发明名称 Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
摘要 Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
申请公布号 US9616077(B2) 申请公布日期 2017.04.11
申请号 US201615083105 申请日期 2016.03.28
申请人 ANTECIP BIOVENTURES II LLC 发明人 Tabuteau Herriot
分类号 A61K31/663;A61K31/675;A61K9/20;A61K9/00;A61K9/28;A61K47/12;A61K45/06 主分类号 A61K31/663
代理机构 K&L Gates LLP 代理人 K&L Gates LLP ;Johnson Brent A.;Cullman Louis C.
主权项 1. A method of treating low back pain, comprising orally administering zoledronic acid in a disodium salt form to a mammal in need thereof, wherein the zoledronic acid in the disodium salt form is administered in an amount and frequency that results in an AUC of zoledronic acid, over a four week period, that is about 100 ng·h/mL to about 2000 ng·h/mL.
地址 New York NY US